Tag: BNT162 mRNA-based vaccine program
FDA grants fast track designation to Pfizer & Biontech’s Covid-19 vaccine...
Pfizer and Biontech announced that two of the companies' four investigational vaccine candidates from their BNT162 mRNA-based vaccine program (BNT162b1 and BNT162b2) being developed...